Senior insider sale
EVP and CFO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$10.78M
23.53K shares
What this filing means
WAGNER CHARLES F JR plans to sell 23.53K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $10.78M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/6/2026ACC: 0001959173-26-000131
Officer· EVP and CFO
Since Apr 2019
23.53K
Shares to sell
$10.78M
Approx. market value
9.53K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Options Granted - 04/10/2019
Cash
1/6/2026
9.53KTotal acquired9.53K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/6/2026 | Options Granted - 04/10/2019 Cash | 9.53K | — |
| Total | 9.53K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
14K
Market value
$6.38M
12/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.53K
Market value
$4.39M
1/6/2026
Total
Units
23.53K
Value
$10.78M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/3/2025 | 14K | $6.38M | — | Completed |
| Planned — Approximate Date | ||||
1/6/2026 | 9.53K | $4.39M | NASDAQ | Planned |
| Total | 23.53K | $10.78M | ||